Skip to main content

Table 1 Patient characteristics, according to mutational signature status

From: Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden

Characteristic

All patients (n = 76)

SBS4 (n = 25)

SBS2/13 (n = 11)

SBS29 (n = 5)

Other (n = 37)

Age at enrollment—years

 

 Mean ± SD

63.7 ± 9.8

63.7 ± 9.2

67.9 ± 8.4

69.8 ± 9.6

65.1 ± 10.6

 Median (range)

67 (34–87)

62 (45–80)

68 (52–81)

75 (58–79)

68 (34–87)

Sex—no. (%)

 

 Female

41 (54)

14 (56)

6 (55)

3 (60)

14 (38)

 Male

35 (46)

11 (44)

5 (45)

2 (40)

23 (62)

Histological diagnosis—no. (%)

 

 Adenocarcinoma

43 (57)

17 (68)

7 (64)

3 (60)

18 (49)

 Squamous-cell carcinoma

11 (14)

3 (12)

1 (9)

1 (20)

6 (16)

 Large cell neuroendrocrine carcinoma

4 (5)

1 (4)

0 (0)

0 (0)

3 (8)

 Other

18 (24)

4 (16)

3 (27)

1 (20)

10 (27)

Clinical stage—no. (%)

 

 I

11 (14)

8 (32)

3 (27)

1 (20)

0 (0)

 II

9 (12)

4 (16)

2 (18)

0 (0)

3 (8)

 III

20 (27)

5 (20)

1 (9)

3 (60)

12 (32)

 IV

36 (47)

8 (32)

5 (46)

1 (20)

22 (60)

Smoking status—no. (%)

 

 Active or former

72 (95)

24 (96)

11 (100)

5 (100)

34 (92)

 Never

3 (4)

1 (4)

0 (0)

0 (0)

2 (5)

 Unknown

1 (1)

0 (4)

0 (0)

0 (0)

1 (3)

PD-L1 status – no. (%)

 

 < 1%

22 (29)

5 (20)

4 (36)

1 (20)

12 (32)

 1–50%

13 (17)

5 (20)

0 (0)

1 (20)

8 (22)

 > 50%

25 (33)

10 (40)

4 (36)

2 (40)

9 (24)

 Unknown

16 (21)

5 (20)

3 (28)

1 (20)

8 (22)